-
TrialScope Adds Eisai to Its Community of Study Sponsors
Oct 6, 2020, 13:08 PM by Michael CroftJERSEY CITY, NJ, US - Oct 6, 2020 - TrialScope, the global leader in clinical trial disclosure and transparency management technology, has added a new study sponsor to its growing customer rosterFull story -
InSysBio to release the new version of DBSolve Optimum
Oct 6, 2020, 09:57 AM by Michael CroftMOSCOW, RUSSIA - Oct 6, 2020 - InSysBio, one of the worlds pioneers of Quantitative Systems Pharmacology (QSP) modeling, releases the new version of mathematical simulation workbench DBSolveOptimum 2020Full story -
Sterling Pharma Solutions launches £11 million Material Science Centre
Oct 6, 2020, 04:53 AM by Michael Croft- Sep 27, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has officially opened its new multi-million-pound Material Science Centre (MSC), after announcing the investment last yearFull story -
10x Genomics Announces Two In Situ Sequencing Acquisitions
Oct 5, 2020, 19:05 PM by Michael CroftBio-IT World 10x Genomics today announced its second in situ sequencing acquisition: Boston-based ReadCoor, Inc. for cash and stock consideration of $350 million. In late August, 10x Genomics’ acquired Stockholm-based Cartana, developers of in situ RNA analysis technology.Full story -
Abzena appoints Giovanni Escobar as SVP and Site Head of Bristol, Pennsylvania Operations
Oct 5, 2020, 13:32 PM by Michael CroftCAMBRIDGE, UNITED KINGDOM - Oct 5, 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Giovanni Escobar as Senior Vice President (SVP) and Site Head of its Bristol OperationsFull story -
VERICHEM LABORATORIES OFFERS LIQUID STABLE, READY-TO-USE, MULTI-ANALYTE ELECTROLYTE STANDARD KIT
Oct 5, 2020, 10:01 AM by Michael CroftPROVIDENCE, RI, UNITED STATES - Oct 5, 2020 - VERICHEM LABORATORIES is pleased to announce the availability of a ready-to-use, liquid stable Electrolyte Standard KitFull story -
Culprit Mutations, Risky (Neandertal) Variants, Genomic Analysis App: COVID-19 Updates
Oct 2, 2020, 10:40 AM by Michael CroftBio-IT World | Genetic variations not driving outcomes, bio-sensing viral translation, pursuit of a passive vaccine, an Android app that analyzes the SARS-CoV-2 genome, potential antibody cocktails, targeting the hairpin, spike protein may be superantigen, implicating MAIT cells, three mutations common to COVID cases in the U.S., naturally occurring lipid and enzyme hold promise, research using breathing human lungs cells, widespread preexisting immunity, and a Neandertal gene variant that triples the risk of severe disease. Plus, an interactive exhibition about COVID-19 and an international team of experts will study how viral diseases "spill over" from animals to humans.Full story -
A Computational Approach to Modeling COVID-19
Oct 2, 2020, 10:10 AM by Michael CroftFull storyBio-IT World | In months since March, the biotech community has rallied to identify how our unique perspectives and skills can help with the COVID-19 pandemic. The computational biologists at QuartzBio were no different. Although the research team wasn’t generating their own COVID-19 data, the collaborative culture was generating and sharing raw data to play with, so the QuartzBio team began building models.
-
Panthera Biopartners concludes Series A financing with Gresham House Ventures as major investor
Oct 2, 2020, 09:26 AM by Michael CroftPRESTON, UNITED KINGDOM - Oct 2, 2020 - Panthera Biopartners (Panthera) has completed a Series A funding round with Gresham House Ventures as a major investorFull story -
A vulnerability in IBM Maximo asset management system, discovered by Positive Technologies, was fixed
Oct 1, 2020, 11:25 AM by Michael CroftFRAMINGHAM, MA, UNITED STATES - Oct 1, 2020 - Framingham, MA (October 1, 2020) -- A vulnerability in IBM Maximo Asset Management software was discovered by Positive Technologies experts Andrey Medov and Arseny SharoglazovFull story -
OSF HealthCare Implements New Digital Solutions to Help Consumers Find the Right Care Online
Oct 1, 2020, 10:54 AM by Michael CroftBOSTON, MA, UNITED STATES - Oct 1, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced that OSF HealthCare, a not-for-profit Catholic health system based in Illinois, is now connecting consumers with care through Kyruus ProviderMatch® for ConsumersFull story -
AARDEX Group partners with BIOCORP to extend digital solutions for precision medication adherence
Oct 1, 2020, 10:00 AM by Michael CroftISSOIRE, FRANCE - Oct 1, 2020 - Belgium-based AARDEX Group, the world leader in medication adherence solutions, today announced a strategic partnership with BIOCORP, a French company specialized in the design, development and manufacture of innovative medical devicesFull story -
GA4GH Announces Strategic Roadmap, Connection Demos
Sep 30, 2020, 17:15 PM by Michael CroftBio-IT World The Global Alliance for Genomics and Health (GA4GH) has announced the release of its 2020-2021 Strategic Roadmap yesterday at the virtual GA4GH 8th Plenary Meeting, and released three 2020 Connection Demos to illustrate the deployments of GA4GH standards.Full story -
Bio-IT World Expo New Product Showcase Voting Opens
Sep 30, 2020, 16:00 PM by Michael CroftFull storyBio-IT World | Voting is open now for the 2020 Bio-IT World Best of Show Awards. This annual new product award highlights entries that are innovative, progressive, and will demonstrably improve the bio-IT industry. This year's finalists include new products from BC Platforms, Benchling, ConvergeHEALTH, Flywheel, Genedata, Genestack, Globus, GNS Healthcare, Igneous, Illumina, Kanda Software, LabTwin, Lifebit, Linguamatics, NetApp, PercayAI, PetaGene, QIAGEN, Qumulo, Rescale, Riffyn, Synthace, Univa, and Zifo Technologies.
-
Sterling Pharma Solutions acquires API facility in the US
Sep 30, 2020, 12:39 PM by Michael CroftGERMANTOWN, WI, US - Sep 30, 2020 - Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcamis Germantown, Wisconsin facility in the USFull story -
Synthetic Biology start up NanoSyrinx secures capital to develop its fully customisable platform for intra-cellular engineering
Sep 30, 2020, 05:08 AM by Michael CroftCOVENTRY, UNITED KINGDOM - Sep 30, 2020 - NanoSyrinx, an emerging biotechnology company developing new therapeutic modalities for Cell & Gene editing, announced the closing of a Pre-Seed financing led by M Ventures (Amsterdam, The Netherlands), the corporate venture capital arm of MerckFull story -
3 Game-changing Cybersecurity Practices Pharmaceuticals Should Take into Consideration
Sep 29, 2020, 13:55 PM by Michael CroftBio-IT World Pharmaceutical breakthroughs and medical research comprise an immeasurably important chunk of the global healthcare industry, warranting an equally robust cybersecurity infrastructure. The healthcare industry is no stranger to the devices of cybercriminals who target hospitals, clinics, research institutions, and pharmaceutical companies in search of highly expensive personal health information to be sold on the darknet.Full story -
Standigm and SK holdings C&C Release an AI-Based Target Identification Platform, iCLUE&ASK™, to Accelerate Drug Discovery Process
Sep 29, 2020, 09:25 AM by Michael CroftSEOUL, SOUTH KOREA - Sep 29, 2020 - Standigm Inc. (Standigm), an artificial intelligence (AI)-based drug discovery company, and SK holdings C&C, CoFull story -
More ‘Omics for SARS-CoV-2, Insights into the Spike Protein, Crowdsourcing Questions: COVID-19 Updates
Sep 25, 2020, 11:05 AM by Michael CroftBio-IT World | A Canadian team shares a new mechanism of action for remdesivir, data science groups have computed consensomes (gene expression in the virus) and interactomes (potential molecular mechanisms of pathogenesis) and cryoEM images the spike protein. Plus, NIH funding for new vaccines and the Reliable Response Data Discovery consortium takes COVID-19 patient data questions.Full story -
Ecological Modeling Of Gut Microbiome Points To Probiotic Cures
Sep 24, 2020, 14:25 PM by Michael CroftBio-IT World Fecal microbiota transplantation (FMT), the idea of using fecal material from a healthy person to treat others who are sick, has been proposed for challenging conditions ranging from inflammatory bowel disease to autism and obesity. But to date, robust evidence from randomized clinical trials exists only for the use of FMT to treat recurrent C. difficile infection.Full story